Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research.
Purity:
90.00%
CAS Number:
[2460809-80-5]
Target:
SARS-CoV|||Interleukin|||HBV
* VAT and and shipping costs not included. Errors and price changes excepted